Atlas Trials

An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Clinical trial NCT00201357 · COMPLETED

Trial details

NCT number
NCT00201357
Sponsor
National Health Research Institutes, Taiwan
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone-refractory Prostate Cancer
Start date
2002-10-01
Primary completion
2004-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.